AC
VTAK icon

Armistice Capital’s Catheter Precision VTAK Stock Holding History

Armistice Capital’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,209
Closed -$86.3K – 274
2025
Q1 		$86.3K Buy
13,209
+6,411
+94% +$48.5K ﹤0.01% 205
2024
Q4 		$58.3K Buy
6,798
+4,903
+259% +$42K ﹤0.01% 209
2024
Q3 		$14.2K Sell
1,895
-618
-25% -$19.9K ﹤0.01% 248
2024
Q2 		$279K Sell
2,513
-758
-23% -$77.1K ﹤0.01% 193
2024
Q1 		$302K Buy
3,271
+1,991
+156% +$177K ﹤0.01% 240
2023
Q4 		$98.4K Sell
1,280
-337
-21% -$27.5K ﹤0.01% 257
2023
Q3 		$137K Buy
1,617
+517
+47% +$60.1K ﹤0.01% 212
2023
Q2 		$192K Sell
1,100
-1,521
-58% -$351K ﹤0.01% 178
2023
Q1 		$762K Buy
+2,621
New +$1.42M 0.01% 146

Other funds holding VTAK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Armistice Capital's VTAK Position: Q2 2025 in Review

Armistice Capital sold out of Catheter Precision (VTAK) in Q2 2025, closing a stake of 13,209 shares — an estimated $86.3K sold.

Armistice Capital first reported a position in VTAK in Q1 2023 and held it in 9 quarters. The position peaked at $762K in Q1 2023. 12 funds tracked by Wall St. Rank hold VTAK as of Q2 2025.

  • Armistice Capital reported no remaining Catheter Precision position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 13,209 Catheter Precision shares in Q2 2025, an estimated $86.3K.
  • Armistice Capital first reported a position in Catheter Precision in Q1 2023 and held it in 9 quarters.
  • Armistice Capital's Catheter Precision position peaked at $762K in Q1 2023.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.